Form 4: Rapid Micro Biosystems Executive Receives Stock Options and Restricted Stock Units

John J. Addington Wilson, Chief Operating Officer of Rapid Micro Biosystems, received stock options and restricted stock units on February 18, 2025.

Summary

• John J. Addington Wilson, the Chief Operating Officer of Rapid Micro Biosystems, received 44,000 shares of Class A Common Stock in the form of restricted stock units (RSUs) on February 18, 2025.
• These RSUs vest in three annual installments, starting with 33.4% on the first anniversary of the grant date (February 18, 2025) and 33.3% on each of the subsequent two anniversaries, contingent upon continuous service.
• Wilson also received an option to buy 89,000 shares of Class A Common Stock at an exercise price of $3.90 on February 18, 2025.
• The stock options vest in 48 substantially equal monthly installments, beginning on March 18, 2025.
• Following these transactions, Wilson directly owns 242,346 shares of Class A Common Stock and has options for 89,000 shares.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, suggesting stability and alignment of interests. The sentiment is neutral to positive as it indicates ongoing commitment from a key executive.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders, incentivizing long-term performance.
• The vesting schedules for both the RSUs and stock options encourage continued service and commitment from the COO.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the equity grants suggest an expectation of continued contributions from the COO.

Industry Context

Equity grants are a common practice in the biotechnology industry to attract, retain, and incentivize key executives. The specific terms of the grants (vesting schedule, exercise price) are tailored to the company's specific circumstances and strategic goals.

Comparison to Industry Standards

• Stock option grants and RSU grants are standard compensation practices for executives in publicly traded companies, particularly in the biotech sector.
• Vesting schedules, such as the three-year annual vesting for RSUs and the four-year monthly vesting for options, are typical to ensure long-term commitment.
• Comparing the size of the grant to similar companies (e.g., Repligen, Bio-Rad) would require analyzing their executive compensation packages and company size.

Stakeholder Impact

• Shareholders: The grants align executive interests with shareholder value creation.
• Employees: The grants can boost morale by demonstrating investment in leadership.
• Executive: The grants provide a financial incentive for continued service and performance.

Key Dates

Keywords

Rapid Micro Biosystems, RPID, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, John J. Addington Wilson, COO